Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Laird Superfood (LSF) Asset Writedowns and Impairment (2021 - 2025)

Historic Asset Writedowns and Impairment for Laird Superfood (LSF) over the last 5 years, with Q3 2025 value amounting to $661103.0.

  • Laird Superfood's Asset Writedowns and Impairment rose 7742.16% to $661103.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 9202.35%. This contributed to the annual value of $599902.0 for FY2024, which is 5288.13% down from last year.
  • Latest data reveals that Laird Superfood reported Asset Writedowns and Impairment of $661103.0 as of Q3 2025, which was up 7742.16% from $300223.0 recorded in Q2 2025.
  • In the past 5 years, Laird Superfood's Asset Writedowns and Impairment ranged from a high of $8.0 million in Q1 2022 and a low of -$160119.0 during Q4 2021
  • For the 5-year period, Laird Superfood's Asset Writedowns and Impairment averaged around $841937.7, with its median value being $144465.0 (2023).
  • Per our database at Business Quant, Laird Superfood's Asset Writedowns and Impairment soared by 772230.71% in 2022 and then plummeted by 9973.14% in 2023.
  • Laird Superfood's Asset Writedowns and Impairment (Quarter) stood at -$160119.0 in 2021, then skyrocketed by 3027.83% to $4.7 million in 2022, then tumbled by 99.73% to $12591.0 in 2023, then soared by 212.79% to $39383.0 in 2024, then soared by 1578.65% to $661103.0 in 2025.
  • Its last three reported values are $661103.0 in Q3 2025, $300223.0 for Q2 2025, and $101715.0 during Q1 2025.